AQLANE Medical initiated the start of their Pivotal Trial

01 September 2015

The use of a polycaprolactone based bulking agent for the treatment of female stress urinary incontinence (SUI); a pivotal trial.

In September 2015 AQLANE Medical™ initiated a prospective, pivotal trial to study the safety and efficacy of Urolon™, our PCL-based bulking agent for female stress urinary incontinence (SUI). The trial will be carried out in the EU. Site selection is completed and patient enrollment underway.

To find out more about this study please click here